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ABSTRACT

DEVELOPMENT OF A PROTOCOL TO MEASURE GENE EXPRESSION
IN THE MOUSE TIBIA

Daniel Hoover

Numerous molecular factors active in bone tissue direct fracture repair and remodeling
which can be altered by disease conditions such as Peripheral Arterial Disease (PAD) and
Osteoporosis. Methods of molecular biology are commonly applied to investigate the
expression and role of these molecular factors. This project presents a robust three-step
protocol for examining gene expression in the mouse tibia. The protocol begins with
isolating RNA from a flash frozen tibia sample. The isolated RNA is reverse transcribed
into cDNA. Finally, PCR is performed to indentify expressed genes. Establishing this
protocol will allow further research into the mechanisms of bone remodeling and repair.
For example, this approach can be used to examine the relationship between osteocyte
apoptosis and angiogenesis in bone tissue, with applications to ischemic conditions and
osteoporosis.
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I Introduction
Project Goal
The purpose of this project was to develop a method for studying gene expression
in mouse tibiae. Specifically, a protocol for analyzing gene expression of the mouse tibia
was needed to pioneer a new area of research into the molecular factors governing
osteocyte behavior under disease conditions such as PAD or Osteoporosis. This protocol
was built on a collection of established methods and required a quarter of
experimentation designed to adjust the existing protocols to overcome specific difficulties
associated with bone tissue. A reliable and accurate method of studying gene expression
in the mouse tibia was created to ensure that molecular biology continues to complement
ongoing research into angiogenesis and bone microcirculation. Bone-vasculature
interactions are many and manifold, but the immediate areas of application of this project
are to the pathologies of Peripheral Arterial Disease (PAD) and Osteoporosis.
Background: Osteoporosis and PAD
Osteoporosis
Overview of Osteoporosis
The World Health Organization quantifies the impact of a disease by the number of
disability-adjusted life years (DALYs) it costs the population. In American and Europe,
fractures resulting from osteoporosis create about 2.8 million DALYs each year 6. Half of
postmenopausal women are predicted to have an osteoporosis related fracture and older
men are also at risk. The fracture itself has less life impact than the pain, loss of
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independence, impaired ambulation, depression, and nursing home admission that often
follow 7. Biologically, osteoporosis has several characteristics. First, there is an overall
decrease in bone density resulting in weaker bone. Second, osteocytes suffer a loss of
viability. Osteocyte function is critical for bone health and their deterioration has a
serious impact on bone remodeling and bone composition regulation 1. Third, in
cancellous bone, osteoporosis results in fewer, narrower trabeculae that are no longer
interconnected in the strong lattice framework of healthy bone 2.
Normal Bone Structure
Two types of bone tissue are present in the human body: cortical or compact bone,
and cancellous or trabecular bone. The basic structural unit of compact bone is the
osteon, consisting of concentric ring-like layers of matrix, termed lamellae, surrounding a
central canal (see Figure 1 below) 1. Collagen fibers interweave through compact bone
tissue and vasculature clusters run through canals in the matrix, supplying oxygen and
nutrients. Osteocytes inhabiting tiny lacunae sense strain conditions on bone and regulate
remodeling activities. Trabecular bone is less dense than compact bone and features
spindly trabeculae, thin spines, and plates of bone lattice that develop along principalstress directions. Within the trabecular framework are cavities containing bone marrow.
Trabecular bone is optimized for strength with a minimum weight of bone. It is found at
the ends of long bones and in the middle of many other bone structures always enclosed
by compact bone 1.
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Figure 1 - Histology of Osseous Tissue 1.

Normal Bone Remodeling
Bone remodeling is both a normal response to changing stress conditions and a
standard repair mechanism to compensate for daily wear. Remodeling is initiated by
osteocytes responding to their environment 2. Osteocytes perceive stresses and strains that
correspond to microcracks in the bone, and release signaling factors that trigger
remodeling. In damaged or growing regions, bone endothelium recruits osteoclasts using
the RANKL/OPG system which will be discussed in more detail later 2, 3. Bone
remodeling is performed by the Basic Multicellular Unit (BMU) which is made up of
3

osteoclasts, osteoblasts, and osteocytes 3. Osteoclasts function to resorb old or damaged
bone (see Figure 2). They produce VEGF for the early stages of remodeling, which acts
in a variety of capacities to encourage remodeling 3. Osteoblasts deposit new bone (see
Figure 2). Remodeling occurs in cycles beginning with resorption by the osteoclasts and
ending with osteoblast deposition of fresh bone. In normal cancellous bone, remodeling
takes place on the surface of the trabeculae with an average cycle duration of 200 days
(see Figures 5 and 6 below). Resorption occurs relatively quickly, in 30-40 days, while
bone formation occurs over a period of 150 days 3. In cortical bone, osteoclasts travel in
resorbing “cutting cones” and are directly followed by osteoblasts that refill the
resorption cavity with new bone as shown in Figures 3 and 4 below. The remodeling
cycle in cortical bone is shorter than the remodeling cycle in trabecular bone; in cortical
bone, it has a median length of 120 days 3, 4.

Figure 2 - Cell Types and Their Roles in Bone Remodeling 5.
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Figure 3 – Diagram of Remodeling in Cortical Bone 5.

Figure 4 – Photomicrograph of Remodeling in Cortical Bone 5.

Figure 5 – Diagram of Remodeling in Trabecular Bone 5.

5

Figure 6 – Photomicrograph of Remodeling in Trabecular Bone 5.

Osteoporotic Bone Remodeling and Treatments
Bone remodeling continues under osteoporotic conditions, but it contributes to the
diseased state rather than restoring bone structure. Osteoblast function is impaired,
lagging far behind counterpart osteoclast activity. In normal bone remodeling, the
remodeling cycle ends with a complete refilling of the resorption lacuna; in osteoporotic
bone, the osteoblasts are unable to refill the entire cavity. Bone density is lost with each
cycle of remodeling 3. There are several treatments currently available for osteoporosis
that target various biochemical pathways in bone. Treatment with Bisphosphonates
targets the inhibition of osteoclast activity. Preventing osteoclast resorption effects a
healthy increase in bone density. Unfortunately, complex instructions for administering
this treatment result in inconsistent adherence to long term therapy 8. In addition, there is
concern that bisphosphonates over-inhibit bone remodeling, impairing fracture repair and
allowing bone microcracks to accumulate 9. Treatment with Strontium Ranelate increases
bone formation and decreases bone resorption 10. Its mechanism of action is not well
understood and may have unforeseen drawbacks as is the case with other modern
treatment strategies. There are no treatments for osteoporosis that focus on the impaired
vascular system even though the vasculature heavily influences bone remodeling 2.
6

Peripheral Arterial Disease (PAD)
Peripheral arterial disease (PAD) is a serious chronic condition of the vasculature.
Blood vessels are occluded by atherosclerotic plaques, impairing blood circulation. The
disease’s effects are most noticeable in the extremities; in the early stages, PAD causes
claudication: intermittent pain during ambulation. In the late stages, PAD progresses to
ischemic ulceration and gangrene ultimately resulting in amputation in 30 percent of
cases 11. Plaques are formed over time by the accumulation of ox-LDL, oxidized low
density lipoprotein, in the subendothelial space 2. The body responds with acute dilation
of collateral vessels to redirect some of the blocked flow. When PAD persists, the chronic
response of the vasculature is to remodel itself to provide less collateral resistance. The
end result however is an exhaustion of the vasculature’s ability to compensate and a
severe reduction in the body’s vasodilation and vessel repair capacity 2.
Link Between PAD and Osteoporosis
The conception of a link between these two pathologies is fascinating and
compelling for several reasons. The diseases share common risk factors such as older
age, physical inactivity, smoking, and diabetes mellitus 12. The intermittent claudication
of PAD restricts physical activity and results in less mechanical stimulation of the bone
and less impetus for remodeling 2. PAD often occurs concurrent with low bone mineral
density (BMD). Decreases in bone formation and overall bone mass have been previously
linked to deficiencies in the vasculature network and PAD-affected vasculature is
deficient in many ways 19.
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The potential for PAD and osteoporosis interaction exists because they share the
same biological pathways and similar marker molecules 12. In order for bone regeneration
to take place, angiogenesis must occur to some degree. PAD affected vasculature is
impaired in its ability to undergo both angiogenesis and arteriogenesis. Thus, PAD’s
adverse affects on bone remodeling may contribute to osteoporosis. There may exist a
specific connection centering on the relationship between osteoprotegerin (OPG), RANK,
and RANKL 2. These three molecules work together to regulate remodeling. The excess
osteoclast activity of osteoporosis stimulates OPG production to suppress that osteoclast
activity. The increase in OPG also disrupts the RANK / RANKL interaction that
ordinarily stimulates angiogenesis, leading to a potential lack of the angiogenesis that
ordinarily should accompany bone remodeling 2. Finally, both disease states are vitamin
D deficient and vitamin D therapy has been very successful in patients with PAD and
osteoporosis 2, 12. The reason for these successes could be the general physical inactivity
of patients suffering from each disease. Physical inactivity is common associated with a
lack of vitamin D absorption from the sun. In conclusion, although there is more
correlation than causal evidence at present, this hypothesized relationship between PAD
and osteoporosis is well worth exploring.
Background: Genes of interest:
For this study, six osteocyte genes of interest were selected to design primers (see
Table 1 below). These are expressed in bone tissue at varying times during the
progression of PAD, the disease of osteoporosis, and fracture healing. Studying the
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expression of these and similar factors under different experimental conditions will
advance the current knowledge of molecular mechanisms in bone.
Table 1 - Signal factor molecules related to Osteoporosis, PAD, and fracture healing.

Signal Factor / Molecule
Cytokines (TNF-α)
IL-1, IL-6, TNF-α

Functions
Cytokines contribute to osteoclast activation and
bone resorption 2. TNF-α stimulates OPG production
to suppress osteoclast activity 2. They are expressed
at high levels during days 1 through 3 of bone
remodeling. Cytokines increase extracellular matrix
synthesis and attracts other inflammatory cells. They
promote angiogenesis as well as bone resorption 15.

TGF-β (TGFβ-1)
Transforming Growth
Factor Beta Superfamily

The factors of the TGF-β superfamily are key
regulators of bone development and repair 14. They
target mesenchymal stem cells and osteoprogenitors
and incite cell proliferation of bone forming cells.
TGF-β increases the density of the extracellular
matrix (ECM) and is released throughout fracture
healing process 15.

BMPs (BMP2)
Bone Morphogenetic Proteins

BMPs promote differentiation of mesenchymal cells
into chondrocytes and osteoblasts, and
osteoprogenitors into osteoblasts 15. In addition, they
may stimulate VEGF synthesis 15. Their expression
during fracture healing takes many patterns.

VEGFs (VEGFa)
Vascular Endothelial
Growth Factors

The degree of collateral arteriogenesis depends on
the extent of VEGF and VEGF-A gene expression 2.
For angiogenesis, VEGF incites proliferation and
differentiation of endothelial cells (ECs). The higher
the concentration of VEGF, the more EC
proliferation and differentiation. VEGF also
stimulates EC proliferation during endochondral
formation in the case of fracture 15. It can increase the
rate of fracture repair when administered
exogenously 20.

Angiopoietins (Ang1 & Ang2)

The angiopoietins affect the development of larger
vessels and structures such as collateral branches 15.
The angiopoietin pathway co-regulates angiogenesis
with VEGF.
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Project Plan
As alluded to previously, the behavior of a tissue can be characterized to some
extent by studying the gene expression of its cells. In this case, the protocol was created
to analyze those signaling factors and molecules active in bone tissue by studying the
gene expression of the bone cells. These bone cells contain genetic code in the form of
DNA that is capable of encoding the factors of interest upon activation. The actual
expression of a gene depends on the input the cell is receiving at that point in time. If the
cell is triggered to produce a given factor by external stimuli, then it will transcribe
messenger RNA from the DNA that codes that factor. The messenger RNA will be
translated by ribosomes that assemble the protein or enzyme of interest. The point at
which molecular biologists often intervene is after the DNA has transcribed mRNA. The
protocol presented here begins with the isolation of mRNA from the bone cells.
To obtain gene expression data from the mRNA, three steps were performed postisolation. First, the fragile mRNA was reverse transcribed into double stranded dsRNA or
cDNA. cDNA is less vulnerable to destruction by environmental RNases and can also be
used as starting material for PCR, Polymerase Chain Reaction. Second, a PCR reaction
was run on the newly created cDNA. PCR functions to amplify a low concentration of
cDNA fragments into quantities large enough to visualize 21. Primers bind specific
genetic material from the assortment of cDNA fragments. For this study, primers were
selected to bind cDNAs corresponding to the genes of interest in Table 1. These cDNAs
were amplified during PCR and then visualized by electrophoresis and imaging under UV
light. PCR amplicons were identified by base pair length, corresponding to distance
10

traveled during electrophoresis. If an amplicon was present for a given gene, then that
gene was being expressed, encoding mRNA to produce a certain protein or enzyme by
translation.
RNA is difficult to extract from highly mineralized bone matrix but special
reagents such as QIAzol make extraction possible. The contingency plan, if the Qiagen
reagents failed, was to use a Trizol two step method of RNA isolation.
In conclusion, the project plan was to develop a protocol for analyzing the gene
expression in mouse tibia; its essential components were RNA isolation, the reverse
transcription of cDNA, primer design and PCR, and gel electrophoresis. This protocol
will augment research into osteocyte activity in Osteoporosis and PAD.
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II Methods
Methods Overview
Each tibiae was surgically extracted from the mouse and frozen for storage to
prevent degradation. RNA isolations were performed on the frozen samples. RNA quality
was tested via nanodrop spectrophotometry. If the sample contained quality RNA, it was
reverse transcribed to make cDNA. Finally, cDNA was used as the starting material for
PCR and selected primers were added. The PCR products were visualized on an
electrophoresis tray under UV light.
Methods
The tibia sample was taken from a mouse specimen during surgery. IACUC
guidelines were strictly observed and the animal remained anesthetized. After exposing
the tibia, bone scissors were used to extract the tibia sample. The dissected sample was
frozen to inactivate RNases and preserve the tissue. See Table 2 for an overview of this
procedure.
Table 2 - Tibia Extraction Overview

Starting Material:
Ending Product:
Reagents:
Equipment:

Mouse specimen
Frozen 50 mg mouse tibia sample
Bone scissors, test tube

For the RNA isolation, first all benchtops were wiped down with RNase Zap wipes
to eliminate RNases. Liquid nitrogen was used to flash freeze the sample and cool the
Biopulverizer. Tibia samples were pulverized in the Biopulverizer and placed in a
12

centrifuge tube containing Qiazol solution. The sample was disrupted and homogenized
under the fume hood using the Tissue Tearor. In the fume hood, chloroform was added to
the lysate, the tube was vortexed thoroughly, and the solution was incubated, centrifuged,
and separated. A series of washes and centrifugations purified the RNA in a Qiagen spin
column. The RNA was eluted with the addition of RNase-free water and an absorbance
reading was taken using the nanodrop spectrophotometer to assay RNA concentration.
See Table 3 for an overview of this procedure.
Table 3 - RNA Isolation Overview

Starting Material: Frozen 50 mg mouse tibia sample
Ending Product: Purified RNA
RNeasy Mini Tissue Kit (Qiagen #74104), QIAzol (Qiagen #79306),
Reagents:
liquid nitrogen, β-mercaptoethanol
BioSpec Biopulverizer, BioSpec Tissue Tearor, forceps, heating
Equipment: block, centrifuge, liquid nitrogen container, ice bucket, RNase Zap
wipes, micropipettes, Nanodrop spectrophotometer

To begin the process of reverse transcription, all solutions were thawed, vortexed,
and centrifuged. RNA samples and oligo(dT) primers were added and the reaction was
incubated in the thermocycler. The remaining reagents were added. The reaction was
completed in the thermocycler and the product cDNA was stored at -20°C for future
PCR. See Table 4 for an overview of this procedure.
Table 4 - Reverse Transcription Overview

Starting Material: Purified Quality RNA
Ending Product: cDNA
AffinityScript Multiple Temperature cDNA Synthesis RT Kit
Reagents:
(Agilent #200436)
Equipment: Ice bucket, RNase Zap wipes, micropipettes
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Following cDNA synthesis, PCR was performed using primers designed for genes
of interest. A master mix was prepared containing all the components necessary for PCR
except template cDNA and primers: 10x PCR Buffer, dNTP mix, HotStarTaq DNA
Polymerase, and RNase-free water. Template cDNA was added to the mix, which was
then divided among PCR tubes; the primers were added in forward and reverse pairs.
PCR was performed in the thermocycler, following a cycling protocol similar to the one
in Table 5, but adjusted to be primer specific. After the PCR reaction completed, the
products were analyzed by electrophoresis. See Table 6 for an overview of the entire
PCR procedure.
Table 5 - Thermocycler Protocol Design

15 min

95°C

Denaturation:

0.5-1 min

94°C

Annealing:

0.5-1 min

50-68°C

Extension:

1 min

72°C

# of Cycles:

35

3-step cycle

Initial Activation Step:

Final Extension:

10 min

HotStarTaq DNA Polymerase
requires this heating to activate.
Aim 5°C below Tm of primers.

72°C

Table 6 - PCR Overview

Starting Material: cDNA
Ending Product: Primer-selected amplified cDNA
HotStarTaq DNA Polymerase Kit (Qiagen #203203), dNTPs,
Reagents:
forward and reverse PCR primers (IDT)
BioRad Gradient Thermocycler C1000, PCR tubes, ice bucket,
Equipment:
micropipettes
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The gel electrophoresis visualized the amplified cDNA products of PCR. An
agarose gel was prepared with ethidium bromide. Loading dye was mixed with each PCR
product and with the standard ladder. The samples were loaded into the gel matrix. After
electrophoresis, the finished gel matrix was imaged under UV light. By comparing the
fluorescent bands present in the PCR product lanes to the standard ladder markings, the
primer-selected genes (if they were present) were identified. See Table 7 for an overview
of this procedure.
Table 7 - Gel Electrophoresis Overview

Starting Material: Primer-selected amplified cDNA
Ending Product: Visualized and identified cDNA: gene expression data
Loading dye, standard ladder, agarose, ethidium bromide, TAE
Reagents:
buffer
Electrophoresis: Electrophoresis tray and accessories, electrophoresis
power supply, microwave, digital balance, spatula, Erlenmeyer flask
Equipment:
Imaging: UV imager, Canon G10 camera, laptop with camera
software
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III Results
(a)

Ladder

1A

1B

(b)

2.5
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2
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200

260/280
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250

150

1

100
0.5
50

0

0
1A

1B

Figure 7 - (a) Quality RNA imaged via gel electrophoresis. Left: standard ladder. Middle: sample 1A.
Right: sample 1B. (b) Column graph of RNA concentration (ng/µ
µL) and RNA purity (A260/280).

Figure 7a is an image of two quality RNA samples obtained using the tibia
isolation protocol. Both samples displayed the crisp 18S and 28S bands indicative of a
quality RNA isolate. In theory, the 28S band should be approximately twice as bright as
the 18S band. For both samples, the 28S band is brighter than the 18S band as expected,
but without using an alternate technique, the brightness could not be measured
quantitatively. Figure 7b is a graph of each samples’ nucleic acid concentration and
260/280 ratio as measured with the nanodrop spectrophotometer. The concentration was
high enough to use the RNA in a reverse transcription reaction. In quality RNA, the
260/280 ratio should be approximately 2.0; the sample ratios presented here are excellent.
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Ladder

Ang-1

Ang-2 VEGFa TNF-α
α TGFβ-1 BMP2 GAPDH β-Actin

Figure 8 - PCR amplicons using cDNA reverse transcribed from RNA isolate 1B.

Table 8 - Primers
Gene

5’

F Primer

3’

5’

R Primer

3’

Tm

Ang-1

CCAGAGAATGCCACTCACAATC

CAACCACCACAATCACCAGAAT

62.0°C

Ang-2

CGGAAACTGACTGATGTGGAAG

ATTCCAGAGATGTGGGCATTTT

61.9°C

VEGFa

AAGCCTGACATGAAGGAAGAGG

CACCGATCTGGGAGAGAGAGAT

62.0°C

TNF-α

ACATTGACAGGTCCAGCAAGAA

AAGCACACAGAAAAGCTGCAAG

62.0°C

TGFβ-1

AAGTCAGAGACGTGGGGACTTC

CTTCTCTGTGGAGCTGAAGCAA

62.0°C

BMP2

TGCCCCCTAGTGCTTCTTAGAC

CTTCATGTGCTGGAGTTGAACC

62.0°C

GAPDH

TATGTCGTGGAGTCTACTGGTGTC

AGTTGTCATATTTCTCGTGGTTCAC

56.0°C

β-Actin

CTGACAGACTACCTCATGAAGATCC

GTCTAGAGCAACATAGCACAGCTTC

58.0°C
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Figure 8 above displays the successful results of a PCR performed on a sample of
cDNA. The cDNA sample was prepared from “DH Tibia RNA 1B” shown in figure 7.
The PCR was run using a temperature gradient 56-58°C. TGFβ-1 primers created a
strong amplicon in lane 6 around 1400 base pairs, matching the expected product length
of 1437 base pairs. GAPDH primers created a very strong amplicon in lane 8
corresponding to their expected product length. β-Actin primers created a very strong
amplicon in lane 9 corresponding to their expected product length. Primer details are
specified in table 10.
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IV Discussion
Success of Methodology
The three stages of RNA isolation, reverse transcription, and PCR were completed
successfully. For the RNA isolation, homogenizing the tissue and extracting RNA was
the most difficult step. The Qiagen RNeasy mini kit protocol was not adapted for bone
tissue and produced a low yield of RNA, but homogenizing the tibia in Qiazol reagent
and separating with chloroform solved this problem. This approach yielded a high
concentration of RNA and avoided degradation. Reverse transcription followed easily.
PCR proved difficult at first, but optimizing annealing temperature and using previously
validated primers eventually resulted in success. Future experiments now have a robust
protocol for investigating gene expression in bone tissue.
Potential Improvements
The protocol has room for improvement, however. First, the PCR method
employed only yields qualitative gene expression data. In order to assay the extent of
mRNA transcription, quantitative real time PCR must be performed. Transitioning the
existing protocol to real time PCR will not be difficult; the microcirculation lab already
uses real time PCR for other molecular biology applications. A second need for
improvement is to handpick osteocyte gene targets of interest and optimize these primers.
The primers used in this proof-of-concept study were chosen broadly to look for
amplification of any kind. Future work will require primers specific to certain osteocyte
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gene targets of interest. The proper annealing temperatures for these primers will need to
be established through primer optimization.
Future Research
Future research will focus on the connections between osteocyte gene expression,
angiogenesis, bone remodeling, and osteoporosis. Osteocyte apoptosis is known to
stimulate angiogenesis, presumably by releasing molecular signaling factors. The
microcirculation lab plans to examine the angiogenic factors produced by osteocyte
apoptosis in bone stimulated by axial loading. This is an appropriate follow on to current
work studying the effects of mechanical stimulus induced osteocyte apoptosis on vascular
and mechanical properties of bone tissue. A second potential application for the
microcirculation lab is studying osteocyte gene expression in a mouse model that
simulates osteoporosis, for instance an aged mouse with impaired remodeling. This will
yield more information regarding the progression of osteoporosis and the molecular
reasons for the impaired remodeling observed in cortical and trabecular bone.
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VI Appendix A: Protocols
Bone RNA Isolation Qiagen Mini Lipid Tissue Kit

24

Reverse Transcription Agilent AffinityScript Kit

25

Gel Electrophoresis and Spectrophotometry
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Design and Order Primers
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VII Appendix B: Experimental Setup
RNA Isolation Equipment

Figure 9 - BioSpec Pulverizer (left) and Tissue Tearor (right).

Figure 10 - Nanodrop spectrophotometer for assaying RNA concentration and purity.

Figure 11 - Gel electrophoresis apparatus.

RT and PCR Equipment
28

Figure 12 - BioRad Gradient Thermocycler C1000 (left) and display (right).
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Comprehensive Reagents/Equipment List
Table 9 - Reagents/Equipment List
Reagents
Agarose
dNTPs
ethidium bromide
forward and reverse PCR primers
liquid nitrogen
Loading dye
Oligo-dT Primers
HotStarTaq DNA Polymerase Kit #203203
AffinityScript Multiple Temperature cDNA
Synthesis Kit, (50) #200436
RNeasy Mini Tissue Kit (10) #74104
QIAzol 79306
RNase free water
RNase inhibitor
standard ladder
TAE buffer
Equipment
BioRad Gradient Thermocycler C1000
BioSpec Biopulverizer
BioSpec Tissue Tearor
bone scissors
Canon G10 camera
centrifuge
digital balance
electrophoresis power supply
electrophoresis tray and accessories
Erlenmeyer flask
forceps
heating block
ice bucket
laptop
liquid nitrogen container
micropipettes
microwave
Nanodrop 2000 software
Nanodrop spectrophotometer
PCR tubes
RNase Zap wipes
spatula
test tubes

Category
Gel
PCR
Gel
PCR
Isolation
Gel
RT
PCR

Source
Fisher
Qiagen
Fisher
IDT
Cal Poly
Fisher
Qiagen
Qiagen

RT

Agilent

Isolation
Isolation
All
RT
Gel
Gel

Qiagen
Qiagen
Fisher
Qiagen
Fisher
Fisher

PCR
Isolation
Isolation
Extraction
Gel
Several
Gel
Gel
Gel
Gel
Isolation
Several
All
Spec, Gel
Isolation
All
Gel
Spec
Spec
PCR
Iso, RT
Gel
All
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Applied Biosystems

Cost
$138.40
$259.00
-

